You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADAMTS13

Showing 1 - 25 of 84
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Von Willebrand Factor Antigen to A Disintegrin-like and

Not yet recruiting
  • Acute on Chronic Liver Failure
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences.
    Sep 28, 2023

    Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)

    No longer available
    • Thrombotic Thrombocytopenic Purpura (TTP)
    • (no location specified)
    Mar 3, 2023

    Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura (TTP)
    • TAK-755
    • (no location specified)
    Feb 9, 2023

    Acute Myeloid Leukemia, Vitamin D Deficiency, ADAMTS13 Trial in Cairo (Cholecalciferol 2800 I.U. ml oral drops)

    Completed
    • Acute Myeloid Leukemia
    • +3 more
    • Cholecalciferol 2800 I.U. ml oral drops
    • Cairo, Madinaty, Egypt
      Dina Ashraf Abdelhady
    Nov 25, 2021

    Improvement of Immunologic and Molecular Techniques for

    Not yet recruiting
    • Acquired Thrombotic Thrombocytopenic Purpura
    • ADAMTS13 Activity Assays
    • (no location specified)
    May 26, 2022

    Obstetric Antiphospholipid Antibody Syndrome : Contribution of

    Completed
    • Antiphospholipid Antibody Syndrome in Pregnancy
    • To study the prognostic value on the occurrence of pre-eclampsia, ADAMTS13 (ADAMTS13 protein and autoantibodies) in patients diagnosed with oAPS
    • Nîmes Cedex 09, France
      CHU de Nîmes - Hôpital Universitaire Carémea
    Jan 26, 2021

    Thrombotic Thrombocytopenic Purpura, Acquired Trial (Caplacizumab)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura, Acquired
    • (no location specified)
    Jan 19, 2021

    Thrombotic Thrombocytopenic Purpura Trial in United States (rituximab)

    Completed
    Has Results
    • Thrombotic Thrombocytopenic Purpura
    • rituximab
    • Atlanta, Georgia
    • +3 more
    Aug 13, 2021

    ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF

    Unknown status
    • Liver Cirrhosis
      • Roma, Italy
        Raimondo De Cristofaro
      Nov 9, 2020

      Congenital Thrombotic Thrombocytopenic Purpura Trial in Worldwide (TAK-755)

      Recruiting
      • Congenital Thrombotic Thrombocytopenic Purpura
      • TAK-755
      • Atlanta, Georgia
      • +20 more
      Mar 29, 2022

      Sickle Cell Disease Trial in United States (SHP655, Placebo)

      Recruiting
      • Sickle Cell Disease
      • Birmingham, Alabama
      • +13 more
      Aug 16, 2021

      Hereditary Thrombotic Thrombocytopenic Purpura (TTP) Trial in Worldwide (Recombinant ADAMTS13)

      Completed
      • Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
      • Recombinant ADAMTS13
      • Dublin, Ohio
      • +10 more
      May 3, 2021

      Thrombotic Thrombocytopenic Purpura (TTP) Trial in Worldwide (BAX930, Standard of care)

      Recruiting
      • Thrombotic Thrombocytopenic Purpura (TTP)
      • BAX930
      • Standard of care
      • Atlanta, Georgia
      • +29 more
      May 4, 2022

      ADAMTS-13 and Von Willebrand Factor Levels and Activities in

      Completed
      • Coagulation Disorder
      • Cirrhosis, Liver
        • Erzurum, Turkey
          Ataturk University Hospital
        Feb 11, 2020

        Hereditary Thrombotic Thrombocytopenic Purpura

        Recruiting
        • Thrombotic Thrombocytopenic Purpura
        • +4 more
        • Observation
        • Oklahoma City, Oklahoma
        • +6 more
        Nov 1, 2022

        Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)

        Not yet recruiting
        • Thrombotic Thrombocytopenic Purpura
        • Aspirin tablet
        • Placebo
        • (no location specified)
        Sep 30, 2022

        Caplacizumab in Treatment of Acquired Thrombotic

        Not yet recruiting
        • Acquired Thrombotic Thrombocytopenic Purpura
        • Cologne, Germany
          University Hospital of Cologne
        May 25, 2023

        Platelet Mimicking Nanoparticles in Patients With Cirrhosis

        Not yet recruiting
        • Liver Cirrhosis
        • Additional blood sampling at the same time and in addition of samplings already done for the patient's standard of care.
        • Villejuif, France
          Anaesthesia unit of the Hepatobiliary Center - Paul Brousse Hosp
        Sep 18, 2023

        Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)

        Not yet recruiting
        • Thrombotic Thrombocytopenic Purpura
        • (no location specified)
        Aug 8, 2022

        Purpura, Thrombotic Thrombocytopenic Trial in London (IdeS (0.25 mg/kg), IdeS (0.50 mg/kg))

        Terminated
        Has Results
        • Purpura, Thrombotic Thrombocytopenic
        • IdeS (0.25 mg/kg)
        • IdeS (0.50 mg/kg)
        • London, Greater London, United Kingdom
          University College London Hospitals NHS
        Sep 12, 2019

        TTP Patients: Italian Experience (ROSCAPLI)

        Recruiting
        • Thrombotic Thrombocytopenic Purpura
        • Roma, Italy
          FPG
        Mar 14, 2023

        Decompensated Cirrhosis Trial in New Delhi (Albumin, Standard of Care)

        Not yet recruiting
        • Decompensated Cirrhosis
        • Albumin
        • Standard of Care
        • New Delhi, Delhi, India
          Institute of Liver & Biliary Sciences
        Jun 29, 2023

        Severe Covid-19 Trial (therapeutic plasmaexchnage)

        Not yet recruiting
        • Severe Covid-19
        • therapeutic plasmaexchnage
        • (no location specified)
        Apr 27, 2021

        EV-TF and the Occurence of Pulmonary Embolism in ARDS

        Not yet recruiting
        • Acute Respiratory Distress Syndrome
        • Blood sample
        • Marseille, France
          Service Médecine intensive et réanimation
        May 15, 2023

        TTP Patients: Italian Experience (ROSCAPLI)

        Not yet recruiting
        • Thrombotic Thrombocytopenic Purpura, Acquired
          • Rome, Italy
            Fondazione Policlinico Universitario Agostino Gemelli, IRCCS
          Feb 21, 2022